Search results
From Self-sufficiency
Page title matches
Page text matches
- ...um]]. Stavudine was approved by the U.S. [[Food and Drug Administration]] (FDA) in June 24, 1994 for adults and in September 6, 1996 for pediatric use and4 KB (574 words) - 16:44, 27 September 2010
- ...ination of tenofovir, emtricitabine and [[efavirenz]], was approved by the FDA on 12 July 2006 and is now available, providing a single daily dose for the ...nline.wsj.com/article/SB121849463154631469.html?mod=us_business_whats_news FDA Clears Viread for Hepatitis B]</ref>.6 KB (871 words) - 16:45, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) in July 2006 under the brand name [[Atripla]], provides HAART in a single Efavirenz was approved by the FDA on September 21, 1998, making it the 14th approved antiretroviral drug.10 KB (1,441 words) - 16:45, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA). It was approved June 21, 1996 for adults and September 11, 1998 for child ...could cause severe liver damage, including liver failure.<ref>[http://www.fda.gov/medwatch/safety/2000/viramune.htm Viramune (nevirapine) letter (Novembe15 KB (2,090 words) - 16:45, 27 September 2010
- The [[Food and Drug Administration]] (FDA) approved indinavir March 13, 1996, making it the eighth approved antiretro3 KB (320 words) - 15:07, 6 July 2010
- Lopinavir/ritonavir was approved by the [[US]] [[Food and Drug Administration|FDA]] on 15 September 2000, and in Europe in April 2001. Its patent will expire ...e Kaletra (lopinavir/ritonavir) with caution <ref name="SafetyLabel200904">FDA Issues Safety Labeling Changes for Kaletra, 2009-04-10, [http://www.medscap8 KB (1,109 words) - 16:45, 27 September 2010
- ...nventions| date=2004-06-03}}.</ref> The [[Food and Drug Administration]] (FDA) approved ritonavir on March 1, 1996, making it the seventh approved antire9 KB (1,233 words) - 15:07, 6 July 2010
- ...$528 in Africa. It was approved by the U.S. [[Food and Drug Administration|FDA]] on July 12, 2006. In the UK, the drug cost to the NHS is {{GB£}}620 per *[http://thebody.com/fda/atripla.html Atripla] article on The Body, an HIV reference site6 KB (773 words) - 16:45, 27 September 2010
- ...nd sixth antiretroviral) approved by the [[Food and Drug Administration]] (FDA). It was approved on December 6, 1995, as Invirase, a poorly-absorbed hard5 KB (717 words) - 15:07, 6 July 2010
- ...icense fees to [[Valeant Pharmaceuticals International]]. The only present FDA-approved indication for these products is in conjunction with interferon ag ...ials against experimental influenza infection were mixed, however, and the FDA ultimately did not approve this indication for ribavirin use in humans, the23 KB (3,222 words) - 16:45, 27 September 2010
- ...Migraine Pain | publisher = [[U.S. Food and Drug Administration]] | work = FDA Consumer magazine | year = 1998}}</ref> ...children. As a result of some lingering concerns about nitrite safety, the FDA and the USDA commissioned a comprehensive review of sodium nitrite's role a21 KB (3,046 words) - 16:45, 27 September 2010
- ...pine has not been officially indicated for either of these purposes by the FDA, it has been used by physicians for these purposes.<ref>[http://www.eperc.m16 KB (2,198 words) - 16:46, 27 September 2010
- The U.S. [[Food and Drug Administration|FDA]] assigned PAS to [[pregnancy category]] C, indicating that it is not known7 KB (879 words) - 16:46, 27 September 2010
- ...States)|Food and Drug Administration]] (FDA) in 1987. Ciprofloxacin has 12 FDA-approved human uses and other veterinary uses, but it is often used for non ...Bayer introduced ciprofloxacin in 1987 and was later approved by the U.S. FDA on 22 October 22 1987 for use in the United States to treat specific bacter88 KB (11,930 words) - 16:46, 27 September 2010
- ...d Drug Administration (United States)|U.S. Food and Drug Administration]] (FDA) approved AzaSite, an ophthalmic formulation of azithromycin, for the treat15 KB (2,008 words) - 16:46, 27 September 2010
- ...for download on [http://www.fda.gov/Drugs/InformationOnDrugs/ucm079750.htm FDA website].</ref> [[generic drug|Generic]] formulations are now available in ...amet.html |archiveurl=http://web.archive.org/web/20071014014507/http://www.fda.gov/oc/qanda/PaxilandAvandamet.html |archivedate=14 October 2007}}</ref> Th66 KB (8,976 words) - 16:47, 27 September 2010
- Valproic acid is also FDA approved for the treatment of [[manic episodes]] associated with [[bipolar | title = FDA Issues Approvable Letter For Stavzor Delayed Release Valproic Acid Capsules25 KB (3,328 words) - 16:47, 27 September 2010
- ...presented a new drug request to the [[U.S. Food and Drug Administration]] (FDA) for fluoxetine.<ref>{{Cite book| last =Breggin| first =Peter R.| coauthors ...ug Administration | month= April | year= 2007| url =http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=018936&TABLE1=OB_Rx | accessd52 KB (7,168 words) - 16:47, 27 September 2010
- ...l adverse effects (approved by the [[U.S. Food and Drug Administration]], "FDA") are deemed insufficient by state courts. ...which reduces risk of surrounding muscle and tissue damage <ref>http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders10 KB (1,347 words) - 21:10, 12 September 2010
- ...ctive therapy" in certain poisoning cases.<ref>{{cite web| url =http://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm130337.h *[http://www.fda.gov/cder/drug/infopage/prussian_blue/Q&A.htm The FDA's page on prussian blue]20 KB (3,004 words) - 16:47, 27 September 2010